These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7974569)

  • 1. Development of aspirin resistance in persons with previous ischemic stroke.
    Helgason CM; Bolin KM; Hoff JA; Winkler SR; Mangat A; Tortorice KL; Brace LD
    Stroke; 1994 Dec; 25(12):2331-6. PubMed ID: 7974569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.
    Komiya T; Kudo M; Urabe T; Mizuno Y
    Stroke; 1994 Dec; 25(12):2337-42. PubMed ID: 7974570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modified platelet aggregation test in patients on ASA and/or clopidogrel].
    Eder C; Funke U; Schulze M; Lutze G; Zimmermann M; Prasse T; Töpfer G
    Hamostaseologie; 2007 Aug; 27(3):163-76. PubMed ID: 17694223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation in patients with atrial fibrillation taking aspirin or warfarin.
    Helgason CM; Hoff JA; Kondos GT; Brace LD
    Stroke; 1993 Oct; 24(10):1458-61. PubMed ID: 8378946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to acetylsalicylic acid in patients after ischemic stroke.
    Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K
    Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
    Stef G; Csiszar A; Ziangmin Z; Ferdinandy P; Ungvari Z; Veress G
    Pharmacol Rep; 2007; 59(4):428-36. PubMed ID: 17901572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
    Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin response and failure in cerebral infarction.
    Helgason CM; Tortorice KL; Winkler SR; Penney DW; Schuler JJ; McClelland TJ; Brace LD
    Stroke; 1993 Mar; 24(3):345-50. PubMed ID: 8446967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between high on aspirin platelet reactivity and oxidative stress in coronary artery by-pass grafted patients.
    Kuliczkowski W; Golanski R; Bijak M; Boryczka K; Kaczmarski J; Watala C; Golanski J
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):151-5. PubMed ID: 26523914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
    Valles J; Santos MT; Aznar J; Osa A; Lago A; Cosin J; Sanchez E; Broekman MJ; Marcus AJ
    Circulation; 1998 Feb; 97(4):350-5. PubMed ID: 9468208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.